BMDCs (1.0 × 105) were mixed with OT-II CD4+ T cells (5.0 × 105) on 96-well plate in cell culture medium. OVA peptide (OVA323–339: 10 ug/mL) was added into cultures and then samples were treated with single or combination TLR ligands (LPS or IMQ LPS or IMQ+LTA, LPS). The ligand concentrations were LPS: 100 ng/mL, IMQ: 10 μg/mL and LTA: 5 ug/mL. Some cultures were treated with LTA only or vehicle control (no-Ag negative control). The culture was incubated at 37 °C for 72 h. At the last 5 h, the cells were re-stimulated with PMA (500 ng/mL) and ionomycin (1 ug/mL) in the presence of GolgiStopTM. The IFN-γ+CD4+ T (Th1) cells and CD69 expression in Th1 cell populations were analyzed by flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.